{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:11:54Z","timestamp":1787587914352,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 32570899"],"award-info":[{"award-number":["No. 32570899"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Natural Science Foundation of Shandong Province","award":["No. ZR2024MH138, ZR2022LZL006"],"award-info":[{"award-number":["No. ZR2024MH138, ZR2022LZL006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08001-8","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:45:07Z","timestamp":1773924307000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["UBE2M promotes malignant phenotypes of prostate cancer through mediating NAA10 neddylation"],"prefix":"10.1186","volume":"24","author":[{"given":"Qixia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxue","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junling","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6298-6192","authenticated-orcid":false,"given":"Shuhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"issue":"3","key":"8001_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"8001_CR2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41585-025-01014-w","volume":"22","author":"C Boixareu","year":"2025","unstructured":"Boixareu C, Taha T, Venkadakrishnan VB, et al. Targeting the tumour cell surface in advanced prostate cancer. Nat Reviews Urol. 2025;22(9):569\u201389.","journal-title":"Nat Reviews Urol"},{"issue":"3","key":"8001_CR3","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1210\/endrev\/bnab002","volume":"42","author":"K Desai","year":"2021","unstructured":"Desai K, Mcmanus JM, Sharifi N. Hormonal Therapy for Prostate Cancer. Endocr Rev. 2021;42(3):354\u201373.","journal-title":"Endocr Rev"},{"issue":"3","key":"8001_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/CCO.0000000000000520","volume":"31","author":"DJ Einstein","year":"2019","unstructured":"Einstein DJ, Arai S, Balk SP. Targeting the androgen receptor and overcoming resistance in prostate cancer. Curr Opin Oncol. 2019;31(3):175\u201382.","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"8001_CR5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ctrv.2013.09.011","volume":"40","author":"A Egan","year":"2014","unstructured":"Egan A, Dong Y, Zhang H, et al. Castration-resistant prostate cancer: adaptive responses in the androgen axis. Cancer Treat Rev. 2014;40(3):426\u201333.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"8001_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/35094009","volume":"1","author":"BJ Feldman","year":"2001","unstructured":"Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer. 2001;1(1):34\u201345.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"8001_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.eururo.2020.09.046","volume":"79","author":"P Cornford","year":"2021","unstructured":"Cornford P, Van Den Bergh RCN, Briers E, et al. Eau-Eanm-Estro-Esur-Siog Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. Eur Urol. 2021;79(2):263\u201382.","journal-title":"Eur Urol"},{"key":"8001_CR8","doi-asserted-by":"crossref","unstructured":"Santonico E. Old and new concepts in ubiquitin and NEDD8 recognition. Biomolecules. 2020, 10(4).","DOI":"10.3390\/biom10040566"},{"issue":"4","key":"8001_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3390\/neurosci3040038","volume":"3","author":"M Govindarajulu","year":"2022","unstructured":"Govindarajulu M, Ramesh S, Shankar T, et al. Role of Neddylation in Neurodegenerative Diseases. NeuroSci. 2022;3(4):533\u201345.","journal-title":"NeuroSci"},{"issue":"1","key":"8001_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41392-024-01800-9","volume":"9","author":"S Zhang","year":"2024","unstructured":"Zhang S, Yu Q, Li Z, et al. Protein neddylation and its role in health and diseases. Signal Transduct Target Ther. 2024;9(1):85.","journal-title":"Signal Transduct Target Ther"},{"key":"8001_CR11","doi-asserted-by":"publisher","first-page":"102191","DOI":"10.1016\/j.arr.2024.102191","volume":"94","author":"M Yu","year":"2024","unstructured":"Yu M, Qian X, Wang Y, et al. Emerging role of NEDD8-mediated neddylation in age-related metabolic diseases. Ageing Res Rev. 2024;94:102191.","journal-title":"Ageing Res Rev"},{"key":"8001_CR12","doi-asserted-by":"publisher","first-page":"1240115","DOI":"10.3389\/fonc.2023.1240115","volume":"13","author":"H Dutta","year":"2023","unstructured":"Dutta H, Jain N. Post-translational modifications and their implications in cancer. Front Oncol. 2023;13:1240115.","journal-title":"Front Oncol"},{"issue":"1","key":"8001_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41392-023-01439-y","volume":"8","author":"X Wu","year":"2023","unstructured":"Wu X, Xu M, Geng M, et al. Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies. Signal Transduct Target Ther. 2023;8(1):220.","journal-title":"Signal Transduct Target Ther"},{"issue":"14","key":"8001_CR14","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.7150\/thno.78876","volume":"13","author":"ZX He","year":"2023","unstructured":"He ZX, Yang WG, Zengyangzong D, et al. Targeting cullin neddylation for cancer and fibrotic diseases. Theranostics. 2023;13(14):5017\u201356.","journal-title":"Theranostics"},{"key":"8001_CR15","doi-asserted-by":"crossref","unstructured":"Vava A, Paccez JD, Wang Y et al. DCUN1D1 Is an Essential Regulator of Prostate Cancer Proliferation and Tumour Growth That Acts through Neddylation of Cullin 1, 3, 4A and 5 and Deregulation of Wnt\/Catenin Pathway. Cells, 2023, 12(15).","DOI":"10.3390\/cells12151973"},{"issue":"5","key":"8001_CR16","doi-asserted-by":"publisher","first-page":"e70708","DOI":"10.1002\/cam4.70708","volume":"14","author":"C Yu","year":"2025","unstructured":"Yu C, Lei H, Hou X, et al. Molecular Mechanisms of ARD1 in Tumors. Cancer Med. 2025;14(5):e70708.","journal-title":"Cancer Med"},{"issue":"7","key":"8001_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0100-7","volume":"50","author":"TTL Vo","year":"2018","unstructured":"Vo TTL, Jeong CH, Lee S, et al. Versatility of ARD1\/NAA10-mediated protein lysine acetylation. Exp Mol Med. 2018;50(7):1\u201313.","journal-title":"Exp Mol Med"},{"issue":"14","key":"8001_CR18","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1002\/pmic.201400631","volume":"15","author":"RD Silva","year":"2015","unstructured":"Silva RD, Martinho RG. Developmental roles of protein N-terminal acetylation. Proteomics. 2015;15(14):2402\u20139.","journal-title":"Proteomics"},{"issue":"1","key":"8001_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-021-01070-w","volume":"14","author":"YC Zheng","year":"2021","unstructured":"Zheng YC, Guo YJ, Wang B, et al. Targeting neddylation E2s: a novel therapeutic strategy in cancer. J Hematol Oncol. 2021;14(1):57.","journal-title":"J Hematol Oncol"},{"issue":"8","key":"8001_CR20","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41419-024-06979-x","volume":"15","author":"X Lin","year":"2024","unstructured":"Lin X, Sun D, Yang S, et al. UBE2M forms a positive feedback loop with estrogen receptor to drive breast cancer progression and drug resistance. Cell Death Dis. 2024;15(8):590.","journal-title":"Cell Death Dis"},{"issue":"1","key":"8001_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41392-020-00226-3","volume":"5","author":"S Wang","year":"2020","unstructured":"Wang S, Xian J, Li L, et al. NEDD8-conjugating enzyme UBC12 as a novel therapeutic target in esophageal squamous cell carcinoma. Signal Transduct Target Ther. 2020;5(1):123.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"8001_CR22","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1002\/ijc.33113","volume":"147","author":"MJ Heo","year":"2020","unstructured":"Heo MJ, Kang SH, Kim YS, et al. UBC12-mediated SREBP-1 neddylation worsens metastatic tumor prognosis. Int J Cancer. 2020;147(9):2550\u201363.","journal-title":"Int J Cancer"},{"key":"8001_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ebiom.2019.06.005","volume":"45","author":"L Li","year":"2019","unstructured":"Li L, Kang J, Zhang W, et al. Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer. EBioMedicine. 2019;45:81\u201391.","journal-title":"EBioMedicine"},{"issue":"6","key":"8001_CR24","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.molcel.2018.06.002","volume":"70","author":"W Zhou","year":"2018","unstructured":"Zhou W, Xu J, Tan M, et al. UBE2M Is a Stress-Inducible Dual E2 for Neddylation and Ubiquitylation that Promotes Targeted Degradation of UBE2F. Mol Cell. 2018;70(6):1008\u2013e246.","journal-title":"Mol Cell"},{"issue":"15","key":"8001_CR25","doi-asserted-by":"publisher","first-page":"e2411429122","DOI":"10.1073\/pnas.2411429122","volume":"122","author":"L Xu","year":"2025","unstructured":"Xu L, Lyu X, Wang Y, et al. Neddylation modification stabilizes LC3B by antagonizing its ubiquitin-mediated degradation and promoting autophagy in skin. Proc Natl Acad Sci U S A. 2025;122(15):e2411429122.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7239","key":"8001_CR26","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nature07884","volume":"458","author":"TA Soucy","year":"2009","unstructured":"Soucy TA, Smith PG, Milhollen MA, et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature. 2009;458(7239):732\u20136.","journal-title":"Nature"},{"issue":"8","key":"8001_CR27","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.cmet.2023.05.011","volume":"35","author":"X Lu","year":"2023","unstructured":"Lu X, Kong X, Wu H, et al. UBE2M-mediated neddylation of TRIM21 regulates obesity-induced inflammation and metabolic disorders. Cell Metabol. 2023;35(8):1390\u2013e4058.","journal-title":"Cell Metabol"},{"issue":"6","key":"8001_CR28","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.cell.2008.07.022","volume":"134","author":"DM Duda","year":"2008","unstructured":"Duda DM, Borg LA, Scott DC, et al. Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation. Cell. 2008;134(6):995\u20131006.","journal-title":"Cell"},{"issue":"5","key":"8001_CR29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/cr.2013.44","volume":"23","author":"W Zhou","year":"2013","unstructured":"Zhou W, Wei W, Sun Y. Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases. Cell Res. 2013;23(5):599\u2013619.","journal-title":"Cell Res"},{"issue":"1","key":"8001_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12943-019-0979-1","volume":"18","author":"L Zhou","year":"2019","unstructured":"Zhou L, Jiang Y, Luo Q, et al. Neddylation: a novel modulator of the tumor microenvironment. Mol Cancer. 2019;18(1):77.","journal-title":"Mol Cancer"},{"issue":"1","key":"8001_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41420-023-01337-w","volume":"9","author":"L Zhou","year":"2023","unstructured":"Zhou L, Lin X, Zhu J, et al. NEDD8-conjugating enzyme E2s: critical targets for cancer therapy. Cell Death Discov. 2023;9(1):23.","journal-title":"Cell Death Discov"},{"issue":"1","key":"8001_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13045-023-01485-7","volume":"16","author":"DJ Fu","year":"2023","unstructured":"Fu DJ, Wang T. Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions. J Hematol Oncol. 2023;16(1):87.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"8001_CR33","doi-asserted-by":"publisher","first-page":"e1008105","DOI":"10.1371\/journal.ppat.1008105","volume":"16","author":"C Gain","year":"2020","unstructured":"Gain C, Malik S, Bhattacharjee S, et al. Proteasomal inhibition triggers viral oncoprotein degradation via autophagy-lysosomal pathway. PLoS Pathog. 2020;16(2):e1008105.","journal-title":"PLoS Pathog"},{"key":"8001_CR34","doi-asserted-by":"crossref","unstructured":"Li Y, Li S, Wu H. Ubiquitination-proteasome system (UPS) and autophagy two main protein degradation machineries in response to cell stress. Cells, 2022, 11(5).","DOI":"10.3390\/cells11050851"},{"key":"8001_CR35","doi-asserted-by":"publisher","first-page":"126801","DOI":"10.1016\/j.ijbiomac.2023.126801","volume":"254","author":"Y-J Guo","year":"2024","unstructured":"Guo Y-J, Pang J-R, Zhang Y, et al. Neddylation-dependent LSD1 destabilization inhibits the stemness and chemoresistance of gastric cancer. Int J Biol Macromol. 2024;254:126801.","journal-title":"Int J Biol Macromol"},{"issue":"7","key":"8001_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0107-0","volume":"50","author":"KJ Kuhns","year":"2018","unstructured":"Kuhns KJ, Zhang G, Wang Z, et al. ARD1\/NAA10 acetylation in prostate cancer. Exp Mol Med. 2018;50(7):1\u20138.","journal-title":"Exp Mol Med"},{"issue":"7","key":"8001_CR37","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41419-020-02786-2","volume":"11","author":"YW Lin","year":"2020","unstructured":"Lin YW, Wen YC, Chu CY, et al. Stabilization of ADAM9 by N-\u03b1-acetyltransferase 10 protein contributes to promoting progression of androgen-independent prostate cancer. Cell Death Dis. 2020;11(7):591.","journal-title":"Cell Death Dis"},{"issue":"8","key":"8001_CR38","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1073\/pnas.1113356109","volume":"109","author":"Z Wang","year":"2012","unstructured":"Wang Z, Wang Z, Guo J, et al. Inactivation of androgen-induced regulator ARD1 inhibits androgen receptor acetylation and prostate tumorigenesis. Proc Natl Acad Sci U S A. 2012;109(8):3053\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8001_CR39","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.redox.2018.09.002","volume":"19","author":"J Kang","year":"2018","unstructured":"Kang J, Chun Y-S, Huh J, et al. FIH permits NAA10 to catalyze the oxygen-dependent lysyl-acetylation of HIF-1\u03b1. Redox Biol. 2018;19:364\u201374.","journal-title":"Redox Biol"},{"issue":"14","key":"8001_CR40","doi-asserted-by":"publisher","first-page":"6760","DOI":"10.1111\/jcmm.16680","volume":"25","author":"S Lv","year":"2021","unstructured":"Lv S, Luo T, Yang Y, et al. Naa10p and IKK\u03b1 interaction regulates EMT in oral squamous cell carcinoma via TGF-\u03b21\/Smad pathway. J Cell Mol Med. 2021;25(14):6760\u201372.","journal-title":"J Cell Mol Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08001-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08001-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08001-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T01:53:27Z","timestamp":1777341207000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08001-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8001"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08001-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Shandong First Medical University (Approval No: R202504160309). All animal experiments were approved by the Animal Ethics Committee of Shandong First Medical University (Approval No: LS2024105).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All co-authors have given their consent to the submitted version of the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Nothing.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"599"}}